2,410 results found

One aspect of PPACA that employers cannot lose sight of is its whistleblower protections. Section 1558 of PPACA added Section 18C to the Fair Labor Standards Act to provide protections to employees subject to retaliation for reporting potential violations of PPACA's consumer protections or affordability assistance provisions.

The CFTC approved amendments to its Whistleblower Rules that will strengthen anti-retaliation protections for whistleblowers and enhance the process for reviewing whistleblower claims.

In a settlement with the US DOJ, Kindred Healthcare, Inc., a skilled nursing and long-term care company, has agreed to pay the federal government more than $125 million for alleged False Claims Act violations.

A number of Congressional committees have held hearings recently to address various health policy issues.

The US Department of Justice (DOJ) and whistleblowers were party to a record number of False Claims Act settlements and judgments in fiscal year 2023.

While the federal False Claims Act typically receives the most attention in FCA circles, more than half the states and the District of Columbia have analogous statutes with qui tam provisions.

On May 31, 2017 the Department of Justice announced that EHR vendor eClinicalWorks (ECW) has agreed to settle a whistleblower suit brought under the False Claims Act (FCA) for $155 million

Companies in the drug, biologic and medical device spaces may encounter compliance challenges, some of which can lead to government enforcement actions and potential civil, and even criminal, liability.

The U.S. Occupational Safety and Health Administration ("OSHA") has released a final rule governing the employee protection provision of Section 402 of the FDA Food Safety Modernization Act.

On October 24, the U.S. Department of Justice (DOJ) announced a record-breaking $145 million settlement with Life Care Centers of America Inc. (Life Care), marking the largest settlement with a skilled nursing facility chain in the DOJ's history.

All Children’s Health System will pay the federal government and state of Florida $7 million to settle allegations that it violated the False Claims Act.

A recent decision from a federal district court in Texas analyzes a number of controversial physician-hospital relationships and explores the limits on qui tam whistleblower suits.

The Department of Defense (DoD) recently adopted a final rule amending the Defense Federal Acquisition Regulation Supplement (DFARS).

In the ever-evolving False Claims Act (FCA) arena, the Government told the court that it intends to move to dismiss a whistleblower suit against United Health Group's Executive Health Resources, Inc.

The federal government collected a record-breaking $5.7 billion in False Claims Act (FCA) recoveries in fiscal year (FY) 2014, up from $3.8 billion in FY 2013.

The U.S. Solicitor General has asked the Supreme Court not to hear an appeal in a False Claims Act ("FCA") case against Takeda North America Pharmaceuticals, Inc.

Every company that receives federal funds in any form—whether by contract, as a subcontractor, through a federal subsidy program or as a grantee— or that has obligations to the federal government, has reason to focus on the False Claims Act (FCA).

In January 2021, Congress passed sweeping AML reform, bringing the AML whistleblower provisions closer in line with the SEC's successful whistleblower program.